I just wanted to invite everyone to share in the success of BioPharma Investor's Biotechnology and Pharmaceutical Stock Blog. Follow Biopharma Investor for the most up to date FDA and Clinical Trial news in the industry. Subscribe to my feed at: http://feeds.feedburner.com/biopharmainvestor.
I recently noticed that BioRunUp.com went from a free site to a pay site. Currently BioRunUp.com is charging subscriptions for $299 a year or $99 a month. BioRunUp is a nice website that is affiliated with MikeHavRx.com. A subscription to MikeHavRx.com is $300 a year or $50 a month. Although I too would like to set up my own BioPharma site and have subscriber content, BioPharma Investor Blog will always be free. I respect the other two sites and think their content is a fair value, but why not just follow my blog instead. Hey you can't beat free stuff. You may say you get what you pay for, but I am just as knowledgeable and creditworthy as the other sites. I simply offer my content for free.
Although I cannot give you the exact same advice as the other two sites, I am charging absolutely nothing. I have worked in the industry and have experience in FDA decisions and Clinical Trials. Like Facebook's Mark Zuckerberg, I see the value in the website and want to keep the content easily accessible for everyone. I apply the same BioRunUp principles and I provide up to the minute news on the Biotech and Pharmaceutical Stock Investments. BioPharma Investor recently won an award for Best Biotech Blog and I would ask you to follow me and subscribe to my feeds. Donate a coffee or two to paypal if you have the chance. It's safe and secure.
I apply due dilegence to stock investing and provide news on FDA outcomes and Clinical Trial Data That does not mean I am always right but no one is 100% perfect on their trades. I provide a unique philosophy on investing and I also have learned about shorting stocks on negative FDA outcomes. Although this is risky, I see it as an important play where Clinical Trials are costing biotechs and pharmaceuticals millions of dollars, only to be rejected by the FDA. But most of the time I stick to sound investments and quality clinical trials with the highest level of success.
I will do my best to provide premium content for my readers and will maintain this blog as a free site. Although I am highly successful at making trades I can't make any promises. This is a high risk, high reward market. Anything and everything can happen. I only will provide you with all the information I have on the latest trends in Biotech and Pharmaceuticals. I try to stay away from the dreaded Pump and Dumps and if I see that it is in fact a pump and dump, I will probably be shorting the stock instead of investing in it for the long run.
Thanks for all your support.
BioPharma Investor
Disclosure: Before investing in any stock you should contact your financial advisor. BioPharma investor is for informational purposes only. I am not a securities broker and this website is for informational purposes only. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.